Bioseeker, Feb 2011
"AnalyticalTool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same
Bioseeker, Feb 2011
"AnalyticalTool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development
Bioseeker, Feb 2011
"AnalyticalTool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at the same
Bioseeker, March 2011
"AnalyticalTool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development
Bioseeker, Feb 2011
"AnalyticalTool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map
Bioseeker, Sep 2011
"AnalyticalTool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment
Bioseeker, Feb 2011
"AnalyticalTool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer
Bioseeker, Feb 2011
"AnalyticalTool – Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers
Bioseeker, June 2006
"AnalyticalTool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody R
Bioseeker, March 2011, Pages: 2628
targets of breast cancer drugs, organized into 193 drug target strategies, and assesses them in breast cancer. This part is based on the following publication: Portfolio Analytics and Planning in the Breast
Bioseeker, Oct 2010, Pages: 2182
targets of breast cancer drugs, organized into 193 drug target strategies, and assesses them in breast cancer.
This part is based on the following publication:
Portfolio Analytics and Planning in the Breast
Bioseeker, Oct 2010, Pages: 2410
targets of breast cancer drugs, organized into 193 drug target strategies, and assesses them in breast cancer.
This part is based on the following publication:
Portfolio Analytics and Planning in the Breast
Bioseeker, March 2011, Pages: 2325
:
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
Part II: Pancreatic Cancer
The pancreatic cancer report part comprises defined and up to date
Bioseeker, March 2011, Pages: 2553
:
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
Part II: Prostate Cancer
The prostate cancer report part comprises defined and up to date
Bioseeker, Oct 2010, Pages: 2107
171 identified targets of pancreatic cancer drugs, organized into 142 drug target profiles, and assesses them in pancreatic cancer.
This part is based on the following publication:
Portfolio Analytics
Bioseeker, March 2011, Pages: 2579
, organized into 193 drug target strategies, and assesses them in breast cancer. This part is based on the following publication: Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change
Bioseeker, March 2011, Pages: 2807
, organized into 193 drug target strategies, and assesses them in breast cancer. This part is based on the following publication: Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change
Bioseeker, May 2010, Pages: 2361
, organized into 193 drug target strategies, and assesses them in breast cancer.
This part is based on the following publication:
Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change
Bioseeker, March 2011, Pages: 2504
drug target strategies, and assesses them in eight different compound strategies in colorectal cancer.
This part is based on the following publication:
A Decision Support Tool for Optimizing
Bioseeker, Sep 2011, Pages: 3516
publication:
Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change is Around the Corner in a Highly Competitive Market Place
Part II: Cancer Vaccines
The cancer vaccine report part comprises